• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Etching of glass microchips with supercritical water?
  Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813

Comprehensive Overview of (1,4-dimethyl-1H-pyrazol-3-yl)methanamine dihydrochloride (CAS No. 2138188-73-3)

(1,4-dimethyl-1H-pyrazol-3-yl)methanamine dihydrochloride (CAS No. 2138188-73-3) is a chemically synthesized compound that has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its pyrazole core structure, is widely studied for its potential applications in drug development and molecular biology. Researchers are particularly interested in its unique properties, which make it a promising candidate for various therapeutic and diagnostic purposes.

The molecular structure of (1,4-dimethyl-1H-pyrazol-3-yl)methanamine dihydrochloride includes a 1,4-dimethyl-1H-pyrazole ring, which is known for its stability and versatility in chemical reactions. The addition of the methanamine group further enhances its reactivity, making it suitable for a range of synthetic applications. The dihydrochloride salt form improves its solubility in aqueous solutions, a critical factor for bioavailability in pharmaceutical formulations.

In recent years, the demand for pyrazole derivatives has surged due to their role in developing novel small-molecule inhibitors and enzyme modulators. This compound, in particular, has been explored for its potential in targeting specific biological pathways, aligning with the growing trend of precision medicine. Its relevance in cancer research and neurodegenerative disease studies has also been highlighted in several peer-reviewed publications.

From a synthetic chemistry perspective, CAS No. 2138188-73-3 is often utilized as a building block for more complex molecules. Its compatibility with various cross-coupling reactions and click chemistry techniques makes it a valuable tool for researchers. The compound’s stability under standard laboratory conditions further adds to its appeal, reducing the need for specialized storage or handling protocols.

Another area of interest is the compound’s potential in drug repurposing, a strategy that has gained traction due to its cost-effectiveness and accelerated development timelines. By leveraging existing data on (1,4-dimethyl-1H-pyrazol-3-yl)methanamine dihydrochloride, scientists are exploring its efficacy in treating conditions beyond its originally intended scope. This approach aligns with the broader shift toward sustainable drug discovery practices.

In the context of bioavailability and pharmacokinetics, the dihydrochloride form of this compound offers distinct advantages. Its enhanced solubility facilitates better absorption in biological systems, a critical factor for oral drug formulations. This property is particularly relevant given the increasing focus on patient-centric drug design, where ease of administration and minimal side effects are prioritized.

The compound’s role in high-throughput screening (HTS) assays cannot be overlooked. As pharmaceutical companies and academic labs increasingly adopt automated screening platforms, the need for reliable and reproducible compounds like CAS No. 2138188-73-3 has grown. Its consistent performance in these assays makes it a staple in modern drug discovery pipelines.

Environmental and green chemistry considerations are also shaping the discourse around this compound. Researchers are investigating ways to synthesize (1,4-dimethyl-1H-pyrazol-3-yl)methanamine dihydrochloride using eco-friendly methods, reducing waste and energy consumption. This aligns with global initiatives to promote sustainable chemistry practices across the pharmaceutical industry.

In summary, (1,4-dimethyl-1H-pyrazol-3-yl)methanamine dihydrochloride (CAS No. 2138188-73-3) represents a versatile and highly valuable compound in contemporary research. Its applications span drug discovery, molecular biology, and material science, reflecting its broad utility. As scientific advancements continue, this compound is poised to play an even greater role in addressing some of the most pressing challenges in healthcare and biotechnology.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)